Braveheart Bio Targets $1.2 Billion Valuation in IPO
The heart-disease drug developer is seeking up to $318.8 million for clinical trials and research.
Archive
The heart-disease drug developer is seeking up to $318.8 million for clinical trials and research.
The live-commerce marketplace is forming an applied AI research group around Shaped's ranking technology.
The design platform is bringing agent development and code generation closer to its collaborative canvas.
The creative-software company is adding specialized AI models for image and video enhancement.
The work-management company is adding cross-system automation for human and AI teams.
The customer-service agent company is adding a French team that connects AI with business processes.
The purchase brings a large catalog of video effects, templates and editing tools inside Apple.
The open-source testing company will strengthen security evaluation for enterprise agents in OpenAI Frontier.